1American Diabetes Association Committee Report.Report of the expert committee on the diagnosis:and classification of diabetes mellitus[J].Diabetes Care,2003,26:S5-S16.
3[2]Joint National Committee on Prevention,Detection,Evaluation,and Treatment of High Blood Pressure.The sixth report of the Joint National Committee on Prevention,Detection,Evaluation,and Treatment of High Blood Pressure.Arch Intern Med,1997,157:2413～2446.
5[4]Gifford RW Jr.An algorithm for the managerment of resistant hypertension.Hypertension,1988,11:Ⅱ101～Ⅱ105.
6[5]Frohlich ED.Classification of resistant hypertension.Hypertension,1988,11:Ⅱ67～Ⅱ70.
7[6]Swales JD,Bing RF,Haegerty A,et al.Treatment of refractory hypertension.Lancet,1982,I:894～896.
8[7]Giudelines subcommittee.1999 World Health OrganizationInternational Society of Hypertension Guidelines for the managenent of hypertension.J Hypertens,1999,17:151～181.
9[8]Fu ML,Herlitz H,Wallukat G,et al.Functional autoimmune epitope on a ladrenergic receptors in patients with malignant hypertension.Lancet,1994,344:1660～1664.
10[9]Fu ML,Herlitz H,Schulze W,et al.Autoantibodies against the angiotensin receptor(AT1)in patients with hypertension.J Hypertens,2000,18:945～953.
5Smith DH,Kramer JM,Perrin N,et al.A randomized trial of directto-patient communication to enhance adherence to beta-blocker therapy following myocardial infarction[J].Arch Intern Med,2008,168:477-483.
6Joo NS,Kim BT.Mobile phone short message service messaging for behaviour modification in a community-based weight control programme in Korea[J].J Telemed Telecare,2007,13:416-420.
